Accuracy of Enzyme-Linked Immunosorbent Assays (ELISAs) in Detecting Antibodies againstMycobacterium lepraein Leprosy Patients: A Systematic Review and Meta-Analysis
Open Access
- 25 November 2018
- journal article
- review article
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2018, 1-11
Abstract
IgM againstMycobacterium lepraemay be detected by enzyme-linked immunosorbent assays (ELISAs) based on phenolic glycolipid I (PGL-I) or natural disaccharide octyl bovine serum albumin (ND-O-BSA) as antigens, and the IgG response can be detected by an ELISA based on lipid droplet protein 1 (LID-1). The titers of antibodies against these antigens vary with operational classification. The aim of this study was to compare the accuracy of ELISAs involving PGL-I and ND-O-BSA with that involving LID-1. We included studies that analyze multibacillary and paucibacillary leprosy cases and evaluate the diagnostic accuracy of ELISAs based on LID-1 and/or PGL-I or ND-O-BSA as antigens to measure antibody titers againstM. leprae. Studies were found via PubMed, the Virtual Health Library Regional Portal, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Índice Bibliográfico Espanhol de Ciências de Saúde, the Brazilian Society of Dermatology, National Institute for Health and Clinical Excellence, Cochrane Library, Embase (the Elsevier database), and Cumulative Index to Nursing and Allied Health Literature. The Quality Assessment of Diagnostic Accuracy Studies served as a methodological validity tool. Quantitative data were extracted using the Standards for Reporting of Diagnostic Accuracy. Sensitivity, specificity, and a diagnostic odds ratio were calculated, and a hierarchical summary receiver-operating characteristic curve and forest plots were constructed. The protocol register code for this meta-analysis is PROSPERO 2017: CRD42017055983. Nineteen studies were included. ND-O-BSA showed better overall performance in terms of sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio when compared with PGL-I and LID-1. The multibacillary group showed better performance on these parameters (than the paucibacillary group did), at 94%, 99%, 129, 0.05, and 2293, respectively. LID-1 did not provide any advantage regarding the overall estimate of sensitivity in comparison with PGL-I or ND-O-BSA.Keywords
This publication has 48 references indexed in Scilit:
- Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technologyBMC Infectious Diseases, 2013
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markersEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Analysis of Antibody Responses to Mycobacterium leprae Phenolic Glycolipid I, Lipoarabinomannan, and Recombinant Proteins To Define Disease Subtype-Specific Antigenic Profiles in LeprosyClinical and Vaccine Immunology, 2011
- Beware of Antibodies to Dietary Proteins in “Antigen-specific” Immunoassays! Falsely Positive Anticytokine Antibody Tests Due to Reactivity with Bovine Serum Albumin in Rheumatoid Arthritis (The Swedish TIRA Project)The Journal of Rheumatology, 2010
- Use of Protein Antigens for Early Serological Diagnosis of LeprosyClinical and Vaccine Immunology, 2007
- The use of whole blood in a dipstick assay for detection of antibodies to Mycobacterium leprae: a field evaluationFEMS Immunology & Medical Microbiology, 1998
- Detection of antibodies to human nerve antigens in sera from leprosy patients by ELISAClinical and Experimental Immunology, 1992
- THE SEROLOGICAL RESPONSE TO THE PHENOLIC GLYCOLIPID OF MYCOBACTERIUM LEPRAE IN AUSTRALIAN AND NEPALI LEPROSY PATIENTSAustralian and New Zealand Journal of Medicine, 1987
- Humans Respond Predominantly with IgM Immunoglobulin to the Species-Specific Glycolipid of Mycobacterium lepraeThe Journal of Infectious Diseases, 1984